FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

PFE

PfizerNYSE · Pharmaceuticals · Health Care
Previous close
27.46
Change
−0.09 / −0.33%
FinDog View
Neutral
52-Week Range
23.58 – 29.21
P/E (TTM)
36.2
Forward P/E
8.6
Based on consensus earnings for the next 12 months
Market Cap
$157B
1M
+2.20%
S&P 500 −2.41% over same period
Volume / Avg Volume
26.0M / 30.0M
0.87× average

Price History

Closing price · USD1M6M1Y5Y
26272829302026-082026-082026-092026-092026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 18.91M6M1Y5Y
102030402025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-04$15.0B0.77 / 0.69+1.57%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-05-05$14.5B0.75 / 0.72+0.30%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-03—— / —+3.92%Pending
FY2025 Q3
Quarter ended 2025-09
2025-11-04—— / —+1.28%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-05—— / —−3.31%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-29—— / —+2.61%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 88 of its 5-year rangeExpensive
5-year range 11.0 – 52.4 · Median 18.3
No buybacks or dividends in the last four quarters
P/E (TTM)
36.2
P/B
1.8
P/S
2.5
Dividend Yield
5.38%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.2% on average on the first trading day after, rising 5 times
Most recent +1.57%
Volatility & Correlation
1-year beta 0.34 · Correlation with S&P 500 0.18Low beta
Annualized volatility 24% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 3 · $3.0MSell 1 · $0.08MNet buying $2.9M
  • 08-12BOURLA ALBERTChairman & CEOBuy$1.0M38,000 shares · Avg price 26.34
  • 08-05Buckley Mortimer JDirectorBuy$0.96M37,632 shares · Avg price 25.52
  • 08-05BLAYLOCK RONALD EDirectorBuy$1.00M39,231 shares · Avg price 25.46
  • 08-05DAMICO JENNIFER B.SVP & ControllerSell$0.08M3,278 shares · Avg price 25.40
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q215.03+2.6%72.8%—-0.250.30-0.04
FY2026 Q114.45+5.4%75.4%—2.692.180.47
FY2025 Q417.56−1.2%70.0%—-1.654.50-0.29
FY2025 Q316.65−5.9%74.9%—3.544.000.62
FY2025 Q214.65+10.3%74.2%—2.91-1.200.51
FY2025 Q113.72−7.8%79.3%—2.971.770.52
FY2024 Q417.76+31.7%66.7%—0.415.800.07
FY2024 Q317.70+36.1%70.3%—4.476.060.78
FY2024 Q213.28−28.1%75.2%—0.04-2.420.01
FY2024 Q114.88—77.3%—3.120.390.55
FY2023 Q413.49−40.4%31.3%—-2.382.65-0.42
FY2023 Q313.01—75.1%—2.33-2.120.41

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
PFEPfizer$157B36.2+2.6%72.8%+2.20%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare